Stephen E. Jones
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
Papers in
-
- Breast Cancer Treatment Studies 63
-
- Lymphoma Diagnosis and Treatment 45
- Co-authors
- Aman U. Buzdar (13 shared papers)Joyce O’Shaughnessy (12 shared papers)Saul A. Rosenberg (8 shared papers)Henry S. Kaplan (7 shared papers)Charles L. Vogel (6 shared papers)Svetislava J. Vukelja (9 shared papers)Alan Webster (7 shared papers)M Casado Martín (3 shared papers)
- Journals
- Cancer (39 papers)Journal of Clinical Oncology (26 papers)Investigational New Drugs (8 papers)Clinical Breast Cancer (8 papers)Recent results in cancer research (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stephen E. Jones
168 papers receiving 17.2k citations
Stephen E. Jones's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 6.3k
- Oncology 4.4k
- Pathology and Forensic Medicine 2.8k
- Pulmonary and Respiratory Medicine 3.5k
- Genetics 1.9k
Countries citing papers authored by Stephen E. Jones
This map shows the geographic impact of Stephen E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Jones more than expected).
Fields of papers citing papers by Stephen E. Jones
This network shows the impact of papers produced by Stephen E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Jones. The network helps show where Stephen E. Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Palbociclib and Letrozole in Advanced Breast Cancer Hit paper breakdown → | 2016 | 2280 |
| 2 | A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer Hit paper breakdown → | 2004 | 1455 |
| 3 | Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Hit paper breakdown → | 2002 | 902 |
| 4 | 1999 | 699 | |
| 5 | Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma Hit paper breakdown → | 1976 | 680 |
| 6 | Non-hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases Hit paper breakdown → | 1973 | 525 |
| 7 | Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial Hit paper breakdown → | 2002 | 515 |
| 8 | 2002 | 474 | |
| 9 | 2005 | 465 | |
| 10 | 2009 | 465 | |
| 11 | 2000 | 439 | |
| 12 | 2006 | 429 | |
| 13 | Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. | 1998 | 364 |
| 14 | 1996 | 336 | |
| 15 | 2011 | 302 | |
| 16 | 2001 | 277 | |
| 17 | 2002 | 260 | |
| 18 | 2003 | 258 | |
| 19 | Adjuvant Therapy of Cancer | 1990 | 242 |
| 20 | 2017 | 234 |
About Stephen E. Jones
Stephen E. Jones is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 171 papers that have together received 18.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (63 papers), Lymphoma Diagnosis and Treatment (45 papers), Cancer Treatment and Pharmacology (21 papers), Advanced Breast Cancer Therapies (18 papers), Estrogen and related hormone effects (14 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer therapeutics and mechanisms (4 papers) and Nausea and vomiting management (4 papers). The work is most often cited by research in Cancer Research (6.3k citations), Oncology (4.4k citations), Pathology and Forensic Medicine (2.8k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Genetics (1.9k citations). Stephen E. Jones has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Aman U. Buzdar, Joyce O’Shaughnessy, Saul A. Rosenberg, Henry S. Kaplan, Charles L. Vogel, Svetislava J. Vukelja, Alan Webster, M Casado Martín, Seock‐Ah Im and Veronique C Dieras. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, Clinical Breast Cancer and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.